News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
233 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (304)
2 (302)
3 (234)
4 (222)
5 (108)
6 (3)
7 (15)
8 (212)
9 (260)
10 (221)
11 (237)
12 (101)
13 (4)
14 (12)
15 (202)
16 (227)
17 (235)
18 (206)
19 (47)
20 (2)
21 (1)
22 (157)
23 (253)
24 (233)
25 (241)
26 (126)
27 (6)
28 (11)
29 (245)
30 (295)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Pharm Country
Hempure Launches Interactive Hemp Chat Bot
Hempure, a CBD supplement company, has launched Dr. Hemphry – an interactive chat bot that answers all your CBD and hemp related questions.
April 24, 2019
·
1 min read
BioMidwest
Global Orthopedic Technology and Manufacturing Community Will Convene for OMTEC® 2019
Implant Coatings, Robotics, Artificial Intelligence, Additive Manufacturing, Inventory Optimization and Medical Device Regulations Among Education Topics
April 24, 2019
·
1 min read
Business
Emendo Biotherapeutics Enters Into Licensing Option Agreement With Takeda for its OMNI Nuclease Program
The funds will be used to further advance Emendo’s novel nuclease gene editing discovery platform and proprietary product development programs.
April 24, 2019
·
2 min read
Pharm Country
Removing Obstacles from the Modern Infertility Patient’s Journey
Results Show Patient Dropout is Low in an Employer-Sponsored High-Touch Program
April 24, 2019
·
4 min read
BioMidwest
Endotronix Receives ISO 13485:2016 Certification
Endotronix’s adherence to internationally recognized standards for the medical device industry demonstrates their commitment to the highest level of product quality.
April 24, 2019
·
2 min read
Business
Biotage Interim Report January - March 2019
New sales record and substantially increased operating profit
April 24, 2019
·
6 min read
Pharm Country
First-Ever National Day Of Action Against Meningitis B Rallies Volunteers In All 50 States To Raise Awareness Of Deadly Disease Affecting Young Adults
Meningitis B is more common in young adults, yet few are receiving the vaccine
April 24, 2019
·
3 min read
Pharm Country
Bayer Named to the 2019 Forbes “America’s Best Employers List”
Company continues upward trend in Large Company Category
April 24, 2019
·
2 min read
Globe Life Sciences Finds That Tinnitus Represents an Untapped Commercial Opportunity
New report from Globe Life Sciences identifies tinnitus to be an attractive but under-recognised commercial opportunity for pharmacotherapies to target
April 24, 2019
·
2 min read
Pharm Country
Eisai To Present Research Findings in Epilepsy and Sleep-Wake Disorders at the 2019 American Academy of Neurology Annual Meeting
Oral presentation highlighting assessment of next-morning residual effects of lemborexant, an investigational agent
April 24, 2019
·
23 min read
Previous
18 of 24
Next